Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-10-23
1994-04-05
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, A61K 3700
Patent
active
053004914
ABSTRACT:
Protozoal infection of human beings or animals is treated with a divalent metal salt of bacitracin. Some infectious agents sensitive to such treatment include human pathogens such as Entamoeba histolytica, Trichomonas vaginilis, Gtardia lamblia, Cryptosporidium parvum, and animal pathogens such as Tritrichomonas foetus and Tritrichomonas gallinae.
REFERENCES:
patent: 2594374 (1950-06-01), Welch
patent: 2676134 (1955-09-01), Felsenfeld
patent: 2803584 (1957-08-01), Hodge et al.
patent: 2903357 (1959-09-01), Zorn
patent: 2985533 (1961-05-01), Zorn
patent: 3021217 (1962-02-01), Zorn
patent: 4693992 (1987-09-01), Young
patent: 5061689 (1991-10-01), Alvarez
Adler et al. J. Bact. 83, 1315-1317 (1962).
Kadison et al., The Journal of Pediatrics 38, pp. 576-589 (1951).
Gillin et al., Journal of Antimicrobial Chemotherapy 8, 305-316 (1981).
Sharma et al., Archives of Opthalmology 108, 5, p. 625 (May 1990).
Lindquist et al., Archives of Opthalmology 106, 1, 73-77 (Jan. 1988).
Most et al., The American Journal of Tropical Medicine 30, 493-497 (1950).
Andrews Barry J.
Bjorvatn Bjarne
Pedersen Steinar
Ronnevig Jorgen R.
Yule Alexander
Apothekernes Laboratorium A.S.
Waddell Frederick E.
Weddington Kevin F.
LandOfFree
Treatment of protozoal infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of protozoal infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of protozoal infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511071